BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34127197)

  • 1. Genome editing in cardiovascular diseases.
    Mani I
    Prog Mol Biol Transl Sci; 2021; 181():289-308. PubMed ID: 34127197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies.
    Nguyen Q; Lim KRQ; Yokota T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing and Pathological Cardiac Hypertrophy.
    Kato T
    Adv Exp Med Biol; 2023; 1396():87-101. PubMed ID: 36454461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing in cardiovascular diseases.
    Strong A; Musunuru K
    Nat Rev Cardiol; 2017 Jan; 14(1):11-20. PubMed ID: 27609628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of CRISPR-Cas systems in neuroscience.
    Bonnerjee D; Bagh S
    Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
    Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
    J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
    Rasoulinejad SA; Maroufi F
    Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Evaluation of Zinc Finger Nucleases.
    Ochiai H; Yamamoto T
    Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases.
    Dong M; Liu J; Liu C; Wang H; Sun W; Liu B
    Pharmacol Res; 2022 Nov; 185():106480. PubMed ID: 36191879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene editing and CRISPR in the clinic: current and future perspectives.
    Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
    Bayarsaikhan D; Bayarsaikhan G; Lee B
    Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.